The UCSF Children’s Cancer Program offers a wide range of clinical trials for children and young adults with cancer in San Francisco, Oakland, Bay Area, Northern California, and western United States. We are a designated Children's Oncology Group (COG) Phase 1 Center. We also have studies from New Approaches to Neuroblastoma Therapy (NANT), Pacific Pediatric Neuro-Oncology Consortium (PNOC), Beat Childhood Cancer (BCC), Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL), Sarcoma Alliance for Research Through Collaboration (SARC), pharmaceutical industry partners, and collaborating university institutions. Many of our trials are available for patients up to 30 years of age.
For patients with newly diagnosed cancer, most clinical trials are offered through our participation in the national Children’s Oncology Group.
For patients with relapsed or refractory cancer, we strive to provide patients access to the newest treatment options in the form of phase 1 and phase 2 clinical trials. Our current open phase 1 and 2 clinical trials are listed below, according to disease category.
If you are interested in learning more about any of these trials, please contact us at 415-476-3831 or CancerClinicalTrials@peds.ucsf.edu.